When Anthropic goes all-in on biology - even edging into drug development - BAIO has to respond in kind.
So this special issue has three parts.
First, The News: what Claude Science is, what Anthropic announced, and what it demonstrated during the launch briefing.
Then, The Voices: how scientists, founders and investors reacted.
Finally, The Insights: what the briefing revealed about where AI × bio is heading.